Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 26-Dec-23 5:07 PM View:  | Boctor Fady See Remarks | Petros Pharmaceuticals, Inc. (PTPI) | 21-Dec-23 | Grant | 49,645 | -- | -- | 100% 0 to 49.65K | |
| 28-Apr-23 6:00 PM View: | Silverman Joshua Director | Petros Pharmaceuticals, Inc. (PTPI) | 26-Apr-23 | Option Exercise | 6,722 | -- | -- | 149% 4.51K to 11.24K | |
| 28-Apr-23 6:03 PM View: | Bradley Greg Director | Petros Pharmaceuticals, Inc. (PTPI) | 26-Apr-23 | Option Exercise | 6,050 | -- | -- | 267% 2.26K to 8.31K | |
| 28-Apr-23 6:01 PM View: | Walker Wayne Remell Director | Petros Pharmaceuticals, Inc. (PTPI) | 26-Apr-23 | Option Exercise | 6,050 | -- | -- | 267% 2.26K to 8.31K | |
| 28-Apr-23 6:02 PM View: | Bernstein Bruce Director | Petros Pharmaceuticals, Inc. (PTPI) | 26-Apr-23 | Option Exercise | 6,050 | -- | -- | 264% 2.3K to 8.35K | |
| 25-Jan-23 4:16 PM View: | Bradley Greg Director | Petros Pharmaceuticals, Inc. (PTPI) | 20-Jan-23 | Option Exercise | 2,264 | -- | -- | 100% 0 to 2.26K | |
| 25-Jan-23 4:17 PM View: | Silverman Joshua Director | Petros Pharmaceuticals, Inc. (PTPI) | 20-Jan-23 | Option Exercise | 2,515 | -- | -- | 126% 2.0K to 4.51K | |
| 25-Jan-23 4:15 PM View: | Bernstein Bruce Director | Petros Pharmaceuticals, Inc. (PTPI) | 20-Jan-23 | Option Exercise | 2,264 | -- | -- | 7075% 32 to 2.3K | |
| 25-Jan-23 4:17 PM View: | Walker Wayne Remell Director | Petros Pharmaceuticals, Inc. (PTPI) | 20-Jan-23 | Option Exercise | 2,264 | -- | -- | 100% 0 to 2.26K | |
| 03-Jan-22 6:13 AM View: | Shulman John D Director 10% Owner | Petros Pharmaceuticals, Inc. (PTPI) | 22-Dec-21 | Market Purchase | 145,773 | $3.43 | $500,001.00 | 3% 5.56M to 5.7M | 6% |
| 30-Nov-21 2:49 PM View: | Shulman John D Director 10% Owner | Petros Pharmaceuticals, Inc. (PTPI) | 29-Nov-21 | Private Purchase | 500,000 | $3.00 | $1,500,000.00 | 10% 5.06M to 5.56M | |
| 21-Oct-21 8:47 AM View: | Shulman John D Director 10% Owner | Petros Pharmaceuticals, Inc. (PTPI) | 18-Oct-21 | Market Purchase | 1,661,810 | $1.72 | $2,850,000.00 | 49% 3.4M to 5.06M | 10% |
| 03-Dec-20 9:58 PM View: | Lavan Keith Chief Financial Officer | Petros Pharmaceuticals, Inc. (PTPI) | 01-Dec-20 | Grant | 975 | -- | -- | 100% 0 to 0.97K | |
| 02-Dec-20 9:10 PM View: | Silverman Joshua Director | Petros Pharmaceuticals, Inc. (PTPI) | 01-Dec-20 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 03-Dec-20 9:59 PM View: | Gesek Andrew President, Timm Medical | Petros Pharmaceuticals, Inc. (PTPI) | 01-Dec-20 | Grant | 97 | -- | -- | 100% 0 to 97 | |
| 03-Dec-20 9:57 PM View: | Shulman John D Director 10% Owner | Petros Pharmaceuticals, Inc. (PTPI) | 01-Dec-20 | Grant | 3,382,420 | -- | -- | 100% 0 to 3.38M |
